Yue Chen · Engineering
Dr. Yue Chen's research lab focuses on improving cardiac treatments for atrial fibrillation using advanced robotic systems and imaging techniques. By integrating multi-modal feedback into MR-guided robotic catheterization, the lab aims to enhance the precision and effectiveness of arrhythmia ablation procedures. Their innovative work seeks to reduce recurrence rates of atrial fibrillation, ultimately leading to better patient outcomes and healthcare solutions.
Andres J Garcia · Engineering
Dr. Andres J Garcia's research lab focuses on biomedical engineering solutions to improve health outcomes for chronic diseases, particularly in lung fibrosis and type 1 diabetes. The lab is pioneering novel biomaterials to understand how mechanical signals influence cellular behavior in lung fibrosis and developing hydrogel technologies that help protect and promote the survival of insulin-producing cells for diabetes treatment. Through advanced tissue models and biocompatible formulations, the lab aims to address significant challenges in current treatment strategies.
James Brandon Dixon · Engineering
Dr. James Brandon Dixon's lab at Georgia Institute of Technology focuses on using advanced biomaterials to improve treatments for lymphedema, a condition that results in swelling and discomfort due to lymphatic system issues. The lab's work includes developing innovative hydrogels and targeted delivery systems to enhance lymph vessel regeneration and improve surgical outcomes. By researching both biological and material engineering approaches, this lab aims to provide effective solutions for millions suffering from lymphedema.
Leslie Chan · Engineering
Leslie Chan's lab at Georgia Tech focuses on developing innovative nanosensors that can be ingested to detect colorectal cancer through breath analysis. This technology aims to enhance early cancer detection in a non-invasive manner, making it easier for people to adhere to screening guidelines. By utilizing enzymatic activity in the intestines, these nanosensors will release detectable biomarkers in breath, potentially saving lives by catching cancer early.